2023
Impact of sex on Transcatheter aortic valve replacement outcomes: Results of a single-center study
See C, Wang Y, Yang Y, Tirziu D, Papoutsidakis N, Francese D, Kaple R, Cleman M, Lansky A, Forrest J. Impact of sex on Transcatheter aortic valve replacement outcomes: Results of a single-center study. International Journal Of Cardiology 2023, 398: 131643. PMID: 38065329, DOI: 10.1016/j.ijcard.2023.131643.Peer-Reviewed Original ResearchNew-generation valvesTranscatheter Aortic Valve Replacement OutcomesImpact of sexTAVR outcomesArtery diseaseYale-New Haven HospitalSTS mortality scorePeripheral artery diseaseSingle-center studyCoronary artery diseaseKaplan-Meier curvesLog-rank testNew Haven HospitalSex-based disparitiesSignificant differencesCardiovascular comorbiditiesSAPIEN 3Transfemoral accessSAPIEN XTConsecutive patientsCox modelingMortality scoreEvolut RFemale sexEvolut PROImpact of New‐Onset Conduction Disturbances following Transcatheter Aortic Valve Replacement on Outcomes: A Single‐Center Study
See C, Wang Y, Huang H, Parise H, Yang Y, Tirziu D, Francese D, Papoutsidakis N, Bader E, Kaple R, Cleman M, Lansky A, Forrest J. Impact of New‐Onset Conduction Disturbances following Transcatheter Aortic Valve Replacement on Outcomes: A Single‐Center Study. Journal Of Interventional Cardiology 2023, 2023: 5390338. PMID: 37292113, PMCID: PMC10247319, DOI: 10.1155/2023/5390338.Peer-Reviewed Original ResearchConceptsTranscatheter aortic valve replacementNew-onset conduction disturbancesAortic valve replacementPersistent conduction disturbancesConduction disturbancesValve replacementSurgical aortic valve replacementSingle-center retrospective analysisYale-New Haven HospitalSingle-center studyCause mortality ratesCause mortality riskLong-term outcomesNew Haven HospitalPeriprocedural factorsAortic stenosisConsecutive patientsTAVR proceduresTerm outcomesRetrospective analysisMortality riskMortality ratePatientsOutcomesPatient's ECGColchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial
Shah T, McCarthy M, Nasir I, Archer H, Ragheb E, Kluger J, Kashyap N, Paredes C, Patel P, Lu J, Kandel P, Song C, Khan M, Huang H, Haq F, Ahmad R, Howes C, Cambi B, Lancaster G, Cleman M, Dela Cruz C, Parise H, Lansky A. Colchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial. BMJ Open 2023, 13: e067910. PMID: 36828654, PMCID: PMC9971831, DOI: 10.1136/bmjopen-2022-067910.Peer-Reviewed Original ResearchConceptsStandard of careHigh-intensity rosuvastatinElectronic medical recordsCOVID-19 diseaseMedical recordsPrimary endpointThromboembolic eventsYale New Haven Health SystemSevere COVID-19 diseaseCOVID-19Prespecified primary endpointVenous thromboembolic eventsRisk of progressionCombination of colchicineSafety monitoring boardCare armHispanics/LatinosTherapeutic anticoagulationIndex hospitalisationIll patientsMedian ageFuture trialsEffect of colchicineClinical trialsMonitoring board
2022
Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy
Patel K, Lansky A, Kereiakes D, Windecker S, Cristea E, Pietras C, Dressler O, Issever M, Curtis M, Bertolet B, Zidar J, Smits P, Díaz V, McLaurin B, Brogno D, Janssens L, Vrolix M, Gómez-Blázquez I, Sahul Z, Kabour A, Salido L, Cleman M, Saito S, Leon M, Baumbach A, Investigators I. Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy. Journal Of The Society For Cardiovascular Angiography & Interventions 2022, 1: 100004. PMID: 39130138, PMCID: PMC11308031, DOI: 10.1016/j.jscai.2021.100004.Peer-Reviewed Original ResearchDrug-eluting stentsTarget lesion failureDP-EESComplex lesionsLesion failureAdverse eventsLesion complexityMajor adverse cardiac eventsSingle-blind clinical trialEnd pointAdverse cardiac eventsChronic coronary syndromePrimary end pointSecondary end pointsTarget lesion revascularizationTarget vessel failureComplex coronary lesionsPercutaneous coronary interventionEverolimus-eluting stentsDrug eluting stentsHigh rateLesion revascularizationCoronary syndromeCardiac eventsCoronary intervention
2021
Impact of Persistent vs. Transient Conduction Abnormalities Within 7 Days Post-TAVR on Mortality: Results of a Single-Center Prospective Registry
See C, Wang Y, Yang Y, Tirziu D, Papoutsidakis N, Kaple R, Cleman M, Lansky A, Forrest J. Impact of Persistent vs. Transient Conduction Abnormalities Within 7 Days Post-TAVR on Mortality: Results of a Single-Center Prospective Registry. Cardiovascular Revascularization Medicine 2021, 28: s43. DOI: 10.1016/j.carrev.2021.06.099.Peer-Reviewed Original ResearchAN ENDOSCOPICALLY GUIDED TRANSESOPHAGEAL ECHOCARDIOGRAM-A NOVEL APPROACH TO TRANSCATHETER MITRAL VALVE REPAIR IN THE SETTING OF A ZENKER'S DIVERTICULUM
Tangel R, Agarwal V, Forrest J, Cleman M, Kaple R, Singh P, Mehta H, Hughes M, Tarangelo N, Muniraj T, DaSilva P, Balan S. AN ENDOSCOPICALLY GUIDED TRANSESOPHAGEAL ECHOCARDIOGRAM-A NOVEL APPROACH TO TRANSCATHETER MITRAL VALVE REPAIR IN THE SETTING OF A ZENKER'S DIVERTICULUM. Journal Of The American College Of Cardiology 2021, 77: 2457. DOI: 10.1016/s0735-1097(21)03812-2.Peer-Reviewed Original ResearchIMPACT OF SEX ON OUTCOMES IN TAVR: RESULTS FROM A SINGLE CENTER PROSPECTIVE REGISTRY
Wang Y, Yang Y, See C, tirziu D, Papoutsidakis N, Kaple R, Cleman M, Lansky A, Forrest J. IMPACT OF SEX ON OUTCOMES IN TAVR: RESULTS FROM A SINGLE CENTER PROSPECTIVE REGISTRY. Journal Of The American College Of Cardiology 2021, 77: 900. DOI: 10.1016/s0735-1097(21)02259-2.Peer-Reviewed Original ResearchIMPACT OF PACEMAKER IMPLANT ≤ 30 DAYS POST TAVR ON MORTALITY: RESULTS OF A SINGLE CENTER PROSPECTIVE REGISTRY
See C, Wang Y, Yang Y, Tirziu D, Papoutsidakis N, Kaple R, Cleman M, Lansky A, Forrest J. IMPACT OF PACEMAKER IMPLANT ≤ 30 DAYS POST TAVR ON MORTALITY: RESULTS OF A SINGLE CENTER PROSPECTIVE REGISTRY. Journal Of The American College Of Cardiology 2021, 77: 974. DOI: 10.1016/s0735-1097(21)02333-0.Peer-Reviewed Original Research
2019
TCT-763 Valve in Valve Transcatheter Aortic Valve Replacement Versus Redo Surgical Aortic Valve Replacement: Real World Outcomes From the National Inpatient Sample (2013–2016)
Kim G, Geirsson A, Cleman M, Forrest J, Kaple R. TCT-763 Valve in Valve Transcatheter Aortic Valve Replacement Versus Redo Surgical Aortic Valve Replacement: Real World Outcomes From the National Inpatient Sample (2013–2016). Journal Of The American College Of Cardiology 2019, 74: b748. DOI: 10.1016/j.jacc.2019.08.902.Peer-Reviewed Original Research
2018
USE OF INTRAVASCULAR ULTRASOUND TO GUIDE INTERVENTION IN ACUTE MYOCARDIAL INFARCTION
Sciria C, Spatz E, Jhamnani S, Cleman M. USE OF INTRAVASCULAR ULTRASOUND TO GUIDE INTERVENTION IN ACUTE MYOCARDIAL INFARCTION. Journal Of The American College Of Cardiology 2018, 71: a2137. DOI: 10.1016/s0735-1097(18)32678-0.Peer-Reviewed Original Research
2016
Impact of Glycoprotein IIb/IIIa Inhibitors Use on Outcomes After Lower Extremity Endovascular Interventions From Nationwide Inpatient Sample (2006–2011)
Arora S, Panaich SS, Patel N, Patel NJ, Lahewala S, Thakkar B, Savani C, Jhamnani S, Singh V, Patel N, Patel S, Sonani R, Patel A, Tripathi B, Deshmukh A, Chothani A, Patel J, Bhatt P, Mohamad T, Remetz MS, Curtis JP, Attaran RR, Mena CI, Schreiber T, Grines C, Cleman M, Forrest JK, Badheka AO. Impact of Glycoprotein IIb/IIIa Inhibitors Use on Outcomes After Lower Extremity Endovascular Interventions From Nationwide Inpatient Sample (2006–2011). Catheterization And Cardiovascular Interventions 2016, 88: 605-616. PMID: 26914274, DOI: 10.1002/ccd.26452.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAmputation, SurgicalCross-Sectional StudiesDatabases, FactualDrug CostsEndovascular ProceduresFemaleHospital CostsHospital MortalityHumansLimb SalvageLogistic ModelsLower ExtremityMaleMiddle AgedMultivariate AnalysisOdds RatioPeripheral Arterial DiseasePlatelet Aggregation InhibitorsPlatelet Glycoprotein GPIIb-IIIa ComplexPropensity ScoreRisk FactorsTime FactorsTreatment OutcomeUnited StatesYoung AdultConceptsGlycoprotein IIb/IIIa inhibitorsPeripheral endovascular interventionsHospital mortalityHospitalization costsEndovascular interventionGPI useAmputation rateUtilization Project Nationwide Inpatient Sample databaseTwo-level hierarchical multivariateIIb/IIIa inhibitorsNationwide Inpatient Sample databaseLower amputation ratesPaucity of dataHospital outcomesPostprocedural complicationsSecondary outcomesPropensity matchingStudy cohortHealthcare costsICD-9Multivariate analysisStudy outcomesSample databaseMortalityHierarchical multivariate
2015
TCT-191 Mechanical Circulatory Support Devices and Transcatheter Aortic Valve Replacement: A Multicenter experience
Singh V, Patel S, Patel N, Savani C, Patel N, Arora S, Panaich S, Cleman M, Mangi A, Forrest J, Badheka A. TCT-191 Mechanical Circulatory Support Devices and Transcatheter Aortic Valve Replacement: A Multicenter experience. Journal Of The American College Of Cardiology 2015, 66: b72. DOI: 10.1016/j.jacc.2015.08.205.Peer-Reviewed Original ResearchCalcium Ions in Inherited Cardiomyopathies
Deftereos S, Papoutsidakis N, Giannopoulos G, Angelidis C, Raisakis K, Bouras G, Davlouros P, Panagopoulou V, Goudevenos J, Cleman M, Lekakis J. Calcium Ions in Inherited Cardiomyopathies. Medicinal Chemistry 2015, 11: 1-1. DOI: 10.2174/1573406411666150928113018.Peer-Reviewed Original ResearchIntra - and Intercellular Calcium Handling in Pulmonary Arterial Hypertension
Mouratoglou S, Giannakoulas G, Deftereos S, Giannopoulos G, Angelidis C, Cleman M, Vassilikos V. Intra - and Intercellular Calcium Handling in Pulmonary Arterial Hypertension. Medicinal Chemistry 2015, 11: 1-1. DOI: 10.2174/1573406411666150928113434.Peer-Reviewed Original ResearchUpdates in Mitral Valve Repair and Replacement
Nichols E, Kapadia S, Feldman T, Kar S, Cleman M, Buchbinder M. Updates in Mitral Valve Repair and Replacement. MD Conference Express 2015, 15: 15-18. DOI: 10.1177/1559897715591155.Peer-Reviewed Original ResearchAORTIC VALVE DISEASE IN ELDERLY: TRENDS OF HOSPITALIZATIONS IN US, 2000-2012
Badheka A, Singh V, Patel N, Arora S, Patel N, Thakkar B, Jhamnani S, Chothani A, Panaich S, Patel J, Deshmukh A, Manvar S, Mangi A, Pfau S, Cleman M, Forrest J. AORTIC VALVE DISEASE IN ELDERLY: TRENDS OF HOSPITALIZATIONS IN US, 2000-2012. Journal Of The American College Of Cardiology 2015, 65: a1951. DOI: 10.1016/s0735-1097(15)61951-9.Peer-Reviewed Original Research
2014
TCT-786 In-Hospital Outcomes of balloon aortic valvuloplasty and percutaneous coronary intervention during the same hospitalization in the US
Singh V, Patel N, Badheka A, Patel N, Macon C, Savani G, Patel J, Thakkar B, Manvar S, Panchal V, Solanki S, Patel N, Chothani A, Kliger C, Schreiber T, O'Neill W, Cohen M, Alfonso C, Grines C, Forrest J, Cleman M, Makkar R. TCT-786 In-Hospital Outcomes of balloon aortic valvuloplasty and percutaneous coronary intervention during the same hospitalization in the US. Journal Of The American College Of Cardiology 2014, 64: b230. DOI: 10.1016/j.jacc.2014.07.859.Peer-Reviewed Original Research
2013
Invasive Hemodynamics
Attaran R, Cleman M. Invasive Hemodynamics. 2013, 1-7. DOI: 10.1007/978-1-4471-4528-8_1.Peer-Reviewed Original Research
2006
P5-40 T-wave amplitude is a more sensitive marker of myocardial ischemia than ST-segment changes in patients undergoing exercise stress testing
Naidu S, Shusterman V, Howes C, Cleman M, O’Connor M, Goldberg A, Lampert R. P5-40 T-wave amplitude is a more sensitive marker of myocardial ischemia than ST-segment changes in patients undergoing exercise stress testing. Heart Rhythm 2006, 3: s273. DOI: 10.1016/j.hrthm.2006.02.818.Peer-Reviewed Original Research
2003
Effects of sirolimus-eluting stents in diabetic patients: Volumetric intravascular ultrasound analysis from the SIRIUS trial
Ako J, Morino Y, Honda Y, Sonoda S, Terashima M, Hassan A, Jaeger J, Simonton C, Roberts D, Cleman M, Leon M, Moses J, Yock P, Fitzgerald P. Effects of sirolimus-eluting stents in diabetic patients: Volumetric intravascular ultrasound analysis from the SIRIUS trial. Journal Of The American College Of Cardiology 2003, 41: 73. DOI: 10.1016/s0735-1097(03)80930-0.Peer-Reviewed Original Research